Periplocin: Difference between revisions
Content deleted Content added
Innerstream (talk | contribs) redundant |
AI analysis |
||
| Line 55: | Line 55: | ||
Periplocin's metabolites, periplocymarin and periplogenin,<ref>{{cite journal |url=https://analyticalsciencejournals.onlinelibrary.wiley.com/doi/10.1002/bmc.5283| authors=Wang, S., Yu, X., Wu, S., Yang, W., Gao, Y., Wang, W. H., Wang, Q., Wei, M., Zhu, M., Wu, J., Yuan, Z., & Li, Y.| title=Simultaneous determination of periplocin, periplocymarin, periplogenin, periplocoside M and periplocoside N of Cortex Periplocae in rat plasma and its application to a pharmacokinetic study. |journal=Biomedical Chromatography | year=2022| volume=36| issue=3| pages=e5283|doi=10.1002/bmc.5283 |pmid=34816469| s2cid=244529941}}</ref> have also shown some pharmacological effects. |
Periplocin's metabolites, periplocymarin and periplogenin,<ref>{{cite journal |url=https://analyticalsciencejournals.onlinelibrary.wiley.com/doi/10.1002/bmc.5283| authors=Wang, S., Yu, X., Wu, S., Yang, W., Gao, Y., Wang, W. H., Wang, Q., Wei, M., Zhu, M., Wu, J., Yuan, Z., & Li, Y.| title=Simultaneous determination of periplocin, periplocymarin, periplogenin, periplocoside M and periplocoside N of Cortex Periplocae in rat plasma and its application to a pharmacokinetic study. |journal=Biomedical Chromatography | year=2022| volume=36| issue=3| pages=e5283|doi=10.1002/bmc.5283 |pmid=34816469| s2cid=244529941}}</ref> have also shown some pharmacological effects. |
||
Potential [[senolytics|senolytic activity]] was suggested by an [[artificial intelligence|AI]] structural analysis of over 4,000 chemicals in 2013.<ref>{{cite web |url=https://www.openaccessgovernment.org/ai-anti-aging-research-drugs-malfunctioning-cells/161082/ |author=NN | title=AI and anti-aging research: Unveiling the latest drug discovery| publisher=Open Access Government |date=June 15, 2023}}</ref> |
|||
==References== |
==References== |
||
{{Reflist}} |
{{Reflist}} |
||
Revision as of 23:11, 26 June 2023
| |
| Names | |
|---|---|
| IUPAC name
3-[(3S,5S,8R,9S,10R,13R,14S,17R)-5,14-dihydroxy-3-[(2R,4S,5R,6R)-4-methoxy-6-methyl-5-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-10,13-dimethyl-2,3,4,6,7,8,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]-2H-furan-5-one
| |
| Identifiers | |
3D model (JSmol)
|
|
| ChemSpider | |
| ECHA InfoCard | 100.208.699 |
| EC Number |
|
PubChem CID
|
|
| UNII | |
CompTox Dashboard (EPA)
|
|
| |
| |
| Properties | |
| C36H56O13 | |
| Molar mass | 696.831 g·mol−1 |
| Hazards | |
| GHS labelling:[1] | |
 
| |
| Danger | |
| H300, H330, H373 | |
| P260, P264, P270, P271, P284, P301+P316, P304+P340, P316, P319, P320, P321, P330, P403+P233, P405, P501 | |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
| |
Periplocin is a plant-derived glycoside whereby the sugar moiety is linked to a steroid. It can be extracted from cortex periplocae (CPP), the dry root of Periploca sepium.[2][3]
CPP's healing activities have long been recognized in traditional Chinese medicine[3] where it has been used to treat rheumatoid arthritis.[2] Scientific studies of CPP have identified over 100 components of which periplocin has been a major focus both for its toxicity as well as for its potential beneficial pharmaceutical effects.[2] Besides the cardiac glycosides with periplocin as its main constituent, the CPP contains different C21-steroidal glycosides such as periplocodides and pregnene derivatives, fatty acids, volatile oils, terpenes, and others.[2]
Higher doses of periplocin are toxic as a cardiac glycoside.[4]
Potential medical applications of periplocin are focused on these areas:[2]
- Anti-inflammatory effects. Periplocin and its derivatives have shown anti-inflammatory effects.
- Antitumor activity. A number of in vivo and in vitro studies suggest that periplocin inhibits tumor growth. Studies show both inhibition of growth as well as induction of apoptosis.
- Cardiotonic activity. Traditional use includes an application for heart failure. Structure and function of cardiac muscle were improved in rats.
Periplocin's metabolites, periplocymarin and periplogenin,[5] have also shown some pharmacological effects.
Potential senolytic activity was suggested by an AI structural analysis of over 4,000 chemicals in 2013.[6]
References
- ^ "Periplocin". pubchem.ncbi.nlm.nih.gov.
- ^ a b c d e "A Review on Phytochemistry and Pharmacology of Cortex Periplocae". Molecules. 21 (12): 1702. 2016. doi:10.3390/molecules21121702. PMC 6272874. PMID 27973416.
{{cite journal}}: Cite uses deprecated parameter|authors=(help) - ^ a b Guo H, Mao H, Pan G, Zhang H, Fan G, Li W, Zhou K, Zhu Y, Yanagihara N, Gao X (2013). "Antagonism of Cortex Periplocae extract-induced catecholamines secretion by Panax notoginseng saponins in cultured bovine adrenal medullary cells by drug combinations". J Ethnopharmacol. 147 (2): 447–455. doi:10.1016/j.jep.2013.03.036. PMID 23524165.
{{cite journal}}: CS1 maint: multiple names: authors list (link) - ^ "Metabolomics study on the periplocin-induced cardiotoxicity and the compatibility of periplocin and Panax notoginseng saponins in reducing cardiotoxicity in rats by GC-MS". Journal of Separation Science. 44 (14): 2785–2797. 2021. doi:10.1002/jssc.202001262. PMID 33961332. S2CID 233985785.
{{cite journal}}: Cite uses deprecated parameter|authors=(help) - ^ "Simultaneous determination of periplocin, periplocymarin, periplogenin, periplocoside M and periplocoside N of Cortex Periplocae in rat plasma and its application to a pharmacokinetic study". Biomedical Chromatography. 36 (3): e5283. 2022. doi:10.1002/bmc.5283. PMID 34816469. S2CID 244529941.
{{cite journal}}: Cite uses deprecated parameter|authors=(help) - ^ NN (June 15, 2023). "AI and anti-aging research: Unveiling the latest drug discovery". Open Access Government.